Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Fatigue and Skeletal Muscle Impact in Severe Axial Spondylarthritis

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
L'enllaç es desa al porta-retalls
EstatEncara no heu contractat
Patrocinadors
University Hospital, Strasbourg, France

Paraules clau

Resum

Axial spondyloarthropathy (SpA) is the most common inflammatory rheumatism (1% of the general population) with important medico-economic consequences.
Fatigue is a major feature of SA. It can be defined as a feeling of reduced muscle capacity, lack of energy and exhaustion. The fatigue reaches an abnormally high level (fatigue severity score (FSS) ≥4, called severe fatigue in this protocol) in more than two thirds of patients with SA.
Skeletal muscle repercussions are present during SA. It is characterized by a decrease in exercise capacity independently of pain and ankylosis but is associated with a decrease in strength and muscle mass, the importance of which varies from one study to another.
The link between fatigue (subjective sensation) and the skeletal muscular impact (objective) of SA has never been studied.

Descripció

This work will:

1. • To study for the first time the implication of the objective skeletal muscular impact in fatigue during SA.

2. • To better characterize the skeletal muscle impact of SA;

3. • To characterize the evolution of the fatigue and the muscular impact under anti-TNFα treatment and the predictive factors of response,

4. • To identify new therapeutic targets for these two complications of SA, which currently have no specific treatment.

Dates

Darrera verificació: 04/30/2019
Primer enviat: 05/05/2019
Inscripció estimada enviada: 05/05/2019
Publicat per primera vegada: 05/06/2019
Última actualització enviada: 05/09/2019
Publicació de l'última actualització: 05/12/2019
Data d'inici de l'estudi real: 09/11/2019
Data estimada de finalització primària: 12/11/2019
Data estimada de finalització de l’estudi: 09/11/2022

Condició o malaltia

Spondylarthritis
Fatigue
Exercise Capacity

Intervenció / tractament

Other: Measurement of aerobic exercise on cycloergometer

Fase

-

Grups de braços

BraçIntervenció / tractament
Other: anti-TNFα treatment and severe fatigue (FSS)
See bellow (section "Interventions") the full description for Measurement of aerobic exercise on cycloergometer Measurement of muscle mass by two-photon absorptiometry: specific study Measurement of Isometric Muscle Strength Blood sampling for measurement of cytokine levels in the blood Measurement of sedentarity Psychological impact Fatigue mesurement Needle muscle of the vastus lateralis (This act will be limited to patients in care at Strasbourg University Hospital n=30)
Other: anti-TNFα treatment and with mild fatigue (FSS <4)
See bellow (section "Interventions") the full description for Measurement of aerobic exercise on cycloergometer Measurement of muscle mass by two-photon absorptiometry: specific study Measurement of Isometric Muscle Strength Blood sampling for measurement of cytokine levels in the blood Measurement of sedentarity Psychological impact Fatigue measurement Needle muscle of the vastus lateralis (This act will be limited to patients in care at Strasbourg University Hospital n=30)

Criteris d'elegibilitat

Edats elegibles per estudiar 18 Years Per a 18 Years
Sexes elegibles per estudiarAll
Accepta voluntaris saludables
Criteris

Inclusion criteria:

-- Axial SA according to the ASAS criteria;

- Indication to start a biotherapy;

- ≥ 18 years old, no upper age limit;

- Subject affiliated to a social health insurance reimbursement;

- Subject having signed a dated and informed consent;

- Woman in childbearing age: negative beta-HCG test and effective contraception;

- Sufficient understanding of French to follow the protocol.

Exclusion criteria:

- Biologic treatments (ongoing or or taken during the 6 months preceding the study),

- Associated extramuscular inflammatory disease (s) (excluding ocular and cutaneous involvement) eg chronic inflammatory bowel disease

- Contraindication to the use of a biologic

- Associated fibromyalgia (Questionnaire score FiRST ≥5) achieved during the V0 visit

- History of coronary artery disease: exercise angina, acute coronary syndrome and / or coronary angioplasty,

- History of lower extremity arterial disease: vascular claudication and / or lower extremity angioplasty

- COPD

- Neuromuscular pathology

- Insufficiency of organ (renal, hepatic pulmonary heart)

- Sleep apnea

- Impossibility of giving the subject informed information (subject in emergency situation, difficulties in understanding the subject, etc.)

- Subject under the protection of justice

- Subject under guardianship or curatorship

- Breastfeeding

- Pregnancy

- Subject in exclusion period defined by another clinical study or participating in a study likely to impact the results of the research

- Corticosteroids in the 15

Resultat

Mesures de resultats primaris

1. Oxygen consumption capacity [At inclusion]

Maximum oxygen consumption capacity on cycloergometer during an incremental effort until exhaustion (VO2 max)

Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge